John L. Villano bought $201k of SACH
Chairman, CEO and President at Sachem Capital Corp.. 124,660 shares at an average of $1.61, traded Nov 20, 2024, filed Nov 21, 2024.
Score components
- +25RoleCEO
- +12Trade size$201k at market
- +3Relative to holdingsHoldings up 7%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -23.9%, 3m -33.3%, 6m -39.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-121362, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | POpen-market purchase Common Stock | +124,660 | $1.61 | $201k | 1,796,329 | Nov 21, 2024 |
Related signals
Other insiders at Sachem Capital Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | SACHsell Sachem Capital Corp. | Leslie Bernhard director | $9,859 2,750 shares | -25% | |
| 20Weak | SACHsell Sachem Capital Corp. | Leslie Bernhard director | $6,821 1,900 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.